Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory Study

Merck & Co, Inc (Kenilworth, NJ) is investing in approaches to enrich clinical trial data and augment decision making through use of digital health technologies, outpatient sampling, and real‐time data access. As part of this strategy, a phase I study was conducted to explore a few technologies...

Descripción completa

Detalles Bibliográficos
Autores principales: Dockendorf, Marissa F., Murthy, Gowri, Bateman, Kevin P., Kothare, Prajakti A., Anderson, Melanie, Xie, Iris, Sachs, Jeffrey R., Burlage, Rubi, Goldman, Andra, Moyer, Matthew, Shah, Jyoti K., Ruba, Rachel, Shipley, Lisa, Harrelson, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617712/
https://www.ncbi.nlm.nih.gov/pubmed/29885208
http://dx.doi.org/10.1002/cpt.1142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617712/
https://www.ncbi.nlm.nih.gov/pubmed/29885208
http://dx.doi.org/10.1002/cpt.1142

Ejemplares similares